Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Oderda

Showing results (71-80 of 175) with videos related to

Pageof 18
Sort By:
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|May 3, 2026
Impact and costs of 3D virtual models in minimally invasive partial nephrectomy: a propensity score-matched analysisMarco Oderda, Federico Lavagno, Marco Allasia, et al.
The Journal of Sexual Medicine|May 14, 2018
A Comparative Study Between 2 Different Grafts Used as Patches After Plaque Incision and Inflatable Penile Prosthesis Implantation for End-Stage Peyronie's DiseaseMarco Falcone, Mirko Preto, Carlo Ceruti, et al.
Urologia Internationalis|October 2, 2013
Prognostic factors of 'high-grade' Ta bladder cancers according to the WHO 2004 classification: are these equivalent to 'high-risk' non-muscle-invasive bladder cancer?Paolo Gontero, Arianna Gillo, Chiara Fiorito, et al.
International Journal of Impotence Research|November 18, 2022
The outcomes of surgical management options for adult acquired buried penisMarco Falcone, Mirko Preto, Massimiliano Timpano, et al.
European Urology|May 1, 2020
The Impact of COVID-19 Outbreak on Uro-oncological Practice Across Europe: Which Burden of Activity Are We Facing Ahead?Marco Oderda, Morgan Roupret, Giancarlo Marra, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 7, 2012
Active surveillance for small renal tumors: have clinical concerns been addressed so far?Paolo Gontero, Steven Joniau, Marco Oderda, et al.
Anti-Cancer Drugs|August 13, 2021
A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agentsAlessandro Rizzo, Marco Oderda, Veronica Mollica, et al.
Diagnostics (Basel, Switzerland)|June 24, 2022
Predictors of Bone Metastases at <sup>68</sup>Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or PersistenceGuido Rovera, Serena Grimaldi, Sara Dall'Armellina, et al.
International Journal of Impotence Research|February 9, 2020
Suprapubic pedicled phalloplasty in transgender men: a multicentric retrospective cohort analysisMarco Falcone, Massimiliano Timpano, Marco Oderda, et al.
Frontiers in Oncology|May 7, 2026
The diagnostic value of mpMRI and PSMA-targeted PET/CT in radiorecurrent prostate cancer: a narrative reviewUmberto Merani, Alessio Venturi, Giorgio Calleris, et al.
Pageof 18

Showing results (71-80 of 175) with videos related to

Sort By:
Pageof 18
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|May 3, 2026
Impact and costs of 3D virtual models in minimally invasive partial nephrectomy: a propensity score-matched analysisMarco Oderda, Federico Lavagno, Marco Allasia, et al.
The Journal of Sexual Medicine|May 14, 2018
A Comparative Study Between 2 Different Grafts Used as Patches After Plaque Incision and Inflatable Penile Prosthesis Implantation for End-Stage Peyronie's DiseaseMarco Falcone, Mirko Preto, Carlo Ceruti, et al.
Urologia Internationalis|October 2, 2013
Prognostic factors of 'high-grade' Ta bladder cancers according to the WHO 2004 classification: are these equivalent to 'high-risk' non-muscle-invasive bladder cancer?Paolo Gontero, Arianna Gillo, Chiara Fiorito, et al.
International Journal of Impotence Research|November 18, 2022
The outcomes of surgical management options for adult acquired buried penisMarco Falcone, Mirko Preto, Massimiliano Timpano, et al.
European Urology|May 1, 2020
The Impact of COVID-19 Outbreak on Uro-oncological Practice Across Europe: Which Burden of Activity Are We Facing Ahead?Marco Oderda, Morgan Roupret, Giancarlo Marra, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 7, 2012
Active surveillance for small renal tumors: have clinical concerns been addressed so far?Paolo Gontero, Steven Joniau, Marco Oderda, et al.
Anti-Cancer Drugs|August 13, 2021
A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agentsAlessandro Rizzo, Marco Oderda, Veronica Mollica, et al.
Diagnostics (Basel, Switzerland)|June 24, 2022
Predictors of Bone Metastases at <sup>68</sup>Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or PersistenceGuido Rovera, Serena Grimaldi, Sara Dall'Armellina, et al.
International Journal of Impotence Research|February 9, 2020
Suprapubic pedicled phalloplasty in transgender men: a multicentric retrospective cohort analysisMarco Falcone, Massimiliano Timpano, Marco Oderda, et al.
Frontiers in Oncology|May 7, 2026
The diagnostic value of mpMRI and PSMA-targeted PET/CT in radiorecurrent prostate cancer: a narrative reviewUmberto Merani, Alessio Venturi, Giorgio Calleris, et al.
Pageof 18